Increased Epithelial Uptake of Protein Antigens in the Ileum of Crohn's Disease Mediated by Tumour Necrosis Factor Alpha

Overview

Journal Gut

Specialty Gastroenterology

Date 2004 Nov 16

PMID 15542521

Citations 58

Authors

J D Soderholm

C Streutker

P-C Yang

C Paterson

P K Singh

D M McKay

P M Sherman

K Croitoru

M H Perdue

Affiliations

Soon will be listed here.

Abstract

Background And Aims: The exact nature of the epithelial barrier defect in Crohn's disease remains to be elucidated. Previously we showed increased permeability to proteins in ileal Crohn's disease. Our aims were to study if this barrier defect (a) involves endocytotic uptake of antigens and (b) is related to low grade inflammation not detectable by histology.

Methods: Macroscopically normal segments of distal ileum of Crohn's disease patients (n = 10) were subgrouped into non-inflamed (histologically unaffected) and slightly inflamed tissues and studied in Ussing chambers, with normal ileal specimens from colon cancer patients (n = 9) as controls. Endocytotic uptake into enterocytes of the protein antigen horseradish peroxidase was assessed by measuring the area of horseradish peroxidase containing endosomes in electron photomicrographs. Mucosal tumour necrosis factor alpha (TNF-alpha) mRNA was quantified using real time polymerase chain reaction. For comparison, the effects of low doses of TNF-alpha on endosomal uptake of horseradish peroxidase were studied in cultured T84 cells grown on filter supports.

Results: The area of horseradish peroxidase containing endosomes was increased (p<0.001) in enterocytes of non-inflamed ileum of Crohn's disease (2.8 (0.7) mum(2)/300 mum(2)) compared with control ileum (0.6 (0.06)). In non-inflamed mucosa, a significant association between endosomal uptake and mucosal expression of TNF-alpha mRNA (p = 0.03) was found. Low concentrations of TNF-alpha (0.25-1.0 ng/ml) enhanced the endosomal uptake of horseradish peroxidase in polarised T84 cells, without affecting transepithelial electrical resistance.

Conclusions: Our findings suggest increased endosomal uptake of antigens in ileal Crohn's disease that may be mediated by TNF-alpha. These data highlight the transcellular route of antigen uptake in barrier dysfunction and implicate the interaction between epithelial cells and the innate immune system in the development of mucosal inflammation.

Citing Articles

Exploring the therapeutic potential of cinnamoyl derivatives in attenuating inflammation in lipopolysaccharide-induced Caco-2 cells.

Reale M, Costantini E, Aielli L, Di Rienzo A, Biase G, Di Stefano A Future Med Chem. 2024; 16(14):1395-1411.

PMID: 39190472 PMC: 11352700. DOI: 10.1080/17568919.2024.2351293.

Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy.

Kong C, Yang M, Yue N, Zhang Y, Tian C, Wei D J Inflamm Res. 2024; 17:5389-5413.

PMID: 39161679 PMC: 11330754. DOI: 10.2147/JIR.S470520.

The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling.

Alsmadi M, Abudaqqa A, Idkaidek N, Qinna N, Al-Ghazawi A AAPS PharmSciTech. 2024; 25(4):86.

PMID: 38605192 DOI: 10.1208/s12249-024-02803-z.

Intestinal Barrier Function and Neurodegenerative Disease.

Wu S, Yang L, Fu Y, Liao Z, Cai D, Liu Z CNS Neurol Disord Drug Targets. 2023; 23(9):1134-1142.

PMID: 38008941 DOI: 10.2174/0118715273264097231116103948.

Macromolecule Translocation across the Intestinal Mucosa of HIV-Infected Patients by Transcytosis and through Apoptotic Leaks.

Krug S, Grunhagen C, Allers K, Bojarski C, Seybold J, Schneider T Cells. 2023; 12(14).

PMID: 37508551 PMC: 10378197. DOI: 10.3390/cells12141887.

References

Gitter A, Wullstein F, Fromm M, Schulzke J . Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology. 2001; 121(6):1320-8. DOI: 10.1053/gast.2001.29694. View

Soderholm J, Olaison G, Peterson K, Franzen L, Lindmark T, Wiren M . Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut. 2002; 50(3):307-13. PMC: 1773145. DOI: 10.1136/gut.50.3.307. View

Schmitz H, Rokos K, Florian P, Gitter A, Fromm M, Scholz P . Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells. AIDS. 2002; 16(7):983-91. DOI: 10.1097/00002030-200205030-00004. View

Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G . Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol. 2002; 97(8):2000-4. DOI: 10.1111/j.1572-0241.2002.05914.x. View

Soderholm J, Yang P, Ceponis P, Vohra A, Riddell R, Sherman P . Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology. 2002; 123(4):1099-108. DOI: 10.1053/gast.2002.36019. View

Musch M, Clarke L, Mamah D, Gawenis L, Zhang Z, Ellsworth W . T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase. J Clin Invest. 2002; 110(11):1739-47. PMC: 151630. DOI: 10.1172/JCI15695. View

Berkes J, Viswanathan V, Savkovic S, Hecht G . Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 2003; 52(3):439-51. PMC: 1773546. DOI: 10.1136/gut.52.3.439. View

Yoo J, Nichols A, Song J, Mammen J, Calvo I, Worrell R . Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes. Am J Physiol Gastrointest Liver Physiol. 2002; 284(4):G703-12. DOI: 10.1152/ajpgi.00214.2002. View

Hisamatsu T, Suzuki M, Reinecker H, Nadeau W, McCormick B, Podolsky D . CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 2003; 124(4):993-1000. DOI: 10.1053/gast.2003.50153. View

10.

Thjodleifsson B, Sigthorsson G, Cariglia N, Reynisdottir I, Gudbjartsson D, Kristjansson K . Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives?. Gastroenterology. 2003; 124(7):1728-37. DOI: 10.1016/s0016-5085(03)00383-4. View

11.

GRAHAM Jr R, Karnovsky M . Glomerular permeability. Ultrastructural cytochemical studies using peroxidases as protein tracers. J Exp Med. 1966; 124(6):1123-34. PMC: 2138332. DOI: 10.1084/jem.124.6.1123. View

12.

Hollander D, Vadheim C, Brettholz E, Petersen G, Delahunty T, Rotter J . Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986; 105(6):883-5. DOI: 10.7326/0003-4819-105-6-883. View

13.

Yamada T, Sartor R, Marshall S, Specian R, Grisham M . Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology. 1993; 104(3):759-71. DOI: 10.1016/0016-5085(93)91011-6. View

14.

May G, Sutherland L, Meddings J . Is small intestinal permeability really increased in relatives of patients with Crohn's disease?. Gastroenterology. 1993; 104(6):1627-32. DOI: 10.1016/0016-5085(93)90638-s. View

15.

Heyman M, Darmon N, Dupont C, Dugas B, Hirribaren A, Blaton M . Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology. 1994; 106(6):1514-23. DOI: 10.1016/0016-5085(94)90405-7. View

16.

Yacyshyn B, Meddings J . CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability. Gastroenterology. 1995; 108(1):132-7. DOI: 10.1016/0016-5085(95)90017-9. View

17.

Saltzman J, Kowdley K, Perrone G, Russell R . Changes in small-intestine permeability with aging. J Am Geriatr Soc. 1995; 43(2):160-4. DOI: 10.1111/j.1532-5415.1995.tb06382.x. View

18.

Bjarnason I, Macpherson A, Hollander D . Intestinal permeability: an overview. Gastroenterology. 1995; 108(5):1566-81. DOI: 10.1016/0016-5085(95)90708-4. View

19.

Hermiston M, Gordon J . Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 1995; 270(5239):1203-7. DOI: 10.1126/science.270.5239.1203. View

20.

Di Paolo M, Merrett M, Crotty B, Jewell D . 5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon. Gut. 1996; 38(1):115-9. PMC: 1382988. DOI: 10.1136/gut.38.1.115. View